Prestige Consumer Healthcare Inc. (PBH)
NYSE · Healthcare
Prestige Consumer Healthcare Inc. EBITDA 2010–2026
Prestige Consumer Healthcare Inc. annual/quarterly ebitda history and growth rate from 2010 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Prestige Consumer Healthcare Inc. ebitda for the quarter ending June 30, 2025 was 79.4 M, a 0.93% decrease year-over-year.
- Prestige Consumer Healthcare Inc. ebitda for the twelve months ending June 30, 2025 was 347.7 M, a 0.52% increase year-over-year.
- Prestige Consumer Healthcare Inc. annual ebitda for 2026 was 340.7 M, a 7.16% decrease from 2025.
- Prestige Consumer Healthcare Inc. annual ebitda for 2025 was 366.9 M, a 1.65% decrease from 2024.
- Prestige Consumer Healthcare Inc. annual ebitda for 2024 was 373.1 M, a 3554.30% increase from 2023.
- Prestige Consumer Healthcare Inc. annual ebitda for 2023 was 10.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Prestige Consumer Healthcare Inc. EBITDA — FAQ
Prestige Consumer Healthcare Inc. (PBH) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PBH's ebitda history?
The chart and table above show Prestige Consumer Healthcare Inc.'s ebitda by year and by quarter, including the growth rate.